Three Crowns Capital

Three Crowns Capital was a Bermuda-based biotech-focused investment banking and advisory firm founded by Peter Svennilson. The firm was described as helping start, finance, and develop biotechnology companies rather than operating as a therapeutic product developer itself. Publicly available references tie the firm to early financing and company formation activities involving multiple biotechnology companies including Tularik, PTC, Chemocentryx, Sunesis, Rinat, Tercica, SomaLogic, Infinity, AVEO, and Five Prime. Available sources indicate that the firm is no longer active and that Svennilson later founded The Column Group. Because Three Crowns Capital appears to have functioned as a financial and company-creation vehicle rather than a drug developer, it does not have a conventional therapeutic pipeline, modalities, or clinical-stage programs.